Tumor-specific Th2 cell responses are associated with tumor immune evasion, and Th2 cytokines such as IL-4 and IL-13 are implicated in the suppression of host immune effector responses to tumors (Gordon and Martinez, 2010; Tosolini et al., 2011). Here, IL13 is linked to neoplasm.